Tammenoms Bakker Juliet
SEC-identified person · CIK 1431159 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Rxsight, Inc. RXST | Director | filed 2021–2026 |
| Ceribell, Inc. CBLL | Director | filed 2024–2026 |
| Rapid Micro Biosystems, INC. [RPID] | Officer | filed 2021–2026 |
| Lexeo Therapeutics, Inc. LXEO | Officer | filed 2023–2023 |
| Vera Therapeutics, Inc. VERA | Officer | filed 2021–2023 |
| Sierra Oncology, Inc. SRRA | Officer | filed 2019–2022 |
| Inozyme Pharma, Inc. INZY | Officer | filed 2020–2022 |
| Eargo, Inc. EAR | Director | filed 2020–2021 |
| Tourmaline Bio, Inc. TRML | Officer | filed 2021–2021 |
| 89bio, Inc. ETNB | Officer | filed 2019–2020 |
| Axonics, Inc. AXNX | Director | filed 2018–2020 |
| Threshold Pharmaceuticals INC THLDD | Officer | filed 2017–2020 |
| Vaxcyte, Inc. PCVX | Officer | filed 2020–2020 |
| Venus Concept Inc. VERO | Director | filed 2019–2020 |
| Tricida, Inc. TCDA | Officer | filed 2018–2018 |
| Aptinyx Inc. APTX | Officer | filed 2018–2018 |
| Aimmune Therapeutics, Inc. AIMT | Officer | filed 2015–2018 |
| Collegium Pharmaceutical, INC COLL | Officer | filed 2015–2017 |
| Kala Pharmaceuticals, Inc. KALA | Officer | filed 2017–2017 |
| Corcept Therapeutics INC CORT | Director | filed 2008–2016 |
| Esperion Therapeutics, Inc. ESPR | Officer | filed 2013–2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.